Other
Gastrectomy
0
Pipeline Programs↗
5
Active Trials↗
1
Companies Involved↗
Gastrectomy is an early-stage landscape with 0 programs across 1 company. The most active players are Solvay Pharmaceuticals.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
21
clinical trials
Completed9 · 43%
Recruiting4 · 19%
Unknown status4 · 19%
Terminated2 · 10%
Withdrawn1 · 5%
Not yet recruiting1 · 5%
Clinical Trials
Trial Activity
21 trials
Cyanoacrylate Versus Omentum for Staple-Line Reinforcement in Sleeve Gastrectomy
Recruiting·—·N/A·NCT07339020·100 enrolled
Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth
Not yet recruiting·—·Phase 3·NCT06934655·150 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)